Sanifar

Sanifar is a Portuguese pharmaceutical company specializing in the marketing, distribution, and commercialization of generic medicines and over-the-counter (OTC) healthcare products. Established in 1990, the company built a robust portfolio targeting key therapeutic areas such as the central nervous system, cardiovascular health, and pain management. In May 2021, Sanifar was acquired by Zentiva, a prominent European generics manufacturer owned by Advent International, as part of a strategic expansion into the Iberian Peninsula. Following the acquisition, Sanifar has been integrated into Zentiva's broader European operations, serving as a vital commercial arm for the Portuguese market. The company focuses on enhancing patient access to affordable high-quality treatments through its extensive local network and supply chain.